RHÖN-KLINIKUM Aktiengesellschaft/€RHK
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM AG is a German healthcare provider operating five hospital sites: Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen, Universitätsklinikum Marburg (UKGM), and Zentralklinik Bad Berka. The company offers inpatient and outpatient medical services, treating approximately 913,000 patients annually. Headquartered in Bad Neustadt a. d. Saale, Germany, RHÖN-KLINIKUM AG employs over 18,700 individuals. In 2020, Asklepios Kliniken GmbH & Co. KGaA acquired a majority stake in RHÖN-KLINIKUM AG, leading to a strategic partnership while maintaining RHÖN-KLINIKUM AG's independence within the Asklepios group. The company focuses on cross-sector healthcare delivery, digital transformation, and sustainability initiatives, including plans to achieve CO₂-neutrality in Scope 1 and Scope 2 emissions by 2040.
Ticker
€RHK
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
18,819
ISIN
DE0007042301
Website
RHK Metrics
BasicAdvanced
€797M
19.87
€0.60
0.02
€0.10
0.84%
Price and volume
Market cap
€797M
Beta
0.02
52-week high
€13.30
52-week low
€11.20
Dividend rate
€0.10
Financial strength
Current ratio
2.254
Quick ratio
1.242
Long term debt to equity
8.813
Total debt to equity
11.261
Interest coverage (TTM)
13.10%
Profitability
EBITDA (TTM)
103.814
Gross margin (TTM)
11.03%
Net profit margin (TTM)
2.10%
Operating margin (TTM)
2.39%
Effective tax rate (TTM)
20.50%
Revenue per employee (TTM)
€100,000
Management effectiveness
Return on assets (TTM)
1.53%
Return on equity (TTM)
3.16%
Valuation
Price to earnings (TTM)
19.874
Price to revenue (TTM)
0.417
Price to book
0.59
Price to tangible book (TTM)
0.68
Dividend yield (TTM)
0.84%
Forward dividend yield
0.84%
Growth
Revenue change (TTM)
7.05%
Earnings per share change (TTM)
-8.04%
3-year revenue growth (CAGR)
5.71%
10-year revenue growth (CAGR)
3.82%
3-year earnings per share growth (CAGR)
14.60%
10-year earnings per share growth (CAGR)
-6.76%
10-year dividend per share growth (CAGR)
-18.77%
Bulls say / Bears say
RHÖN-KLINIKUM AG reported an 8.3% revenue increase in Q1 2025, treating over 240,000 patients, indicating strong operational performance. (Wallstreet:Online)
The company achieved a net income of €9.50 million in Q3 2024, reflecting a 14.92% year-over-year increase, showcasing improved profitability. (Google Finance)
RHÖN-KLINIKUM's earnings per share (EPS) grew to €0.65 in FY 2024 from €0.58 in FY 2023, indicating enhanced shareholder value. (Simply Wall St)
The company's P/E ratio of 23.6x is higher than nearly half of German companies, suggesting potential overvaluation concerns. (Simply Wall St)
Operating expenses increased by 1193.22% in Q3 2024 compared to Q2 2024, which could impact future profitability. (Sirius Investors)
RHÖN-KLINIKUM's stock price declined by 4.8% over the past year, underperforming the Austrian Healthcare industry, which returned 18.5%. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 30 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for RHÖN-KLINIKUM Aktiengesellschaft stock?
RHÖN-KLINIKUM Aktiengesellschaft (RHK) has a market cap of €797M as of July 11, 2025.
What is the P/E ratio for RHÖN-KLINIKUM Aktiengesellschaft stock?
The price to earnings (P/E) ratio for RHÖN-KLINIKUM Aktiengesellschaft (RHK) stock is 19.87 as of July 11, 2025.
Does RHÖN-KLINIKUM Aktiengesellschaft stock pay dividends?
Yes, the RHÖN-KLINIKUM Aktiengesellschaft (RHK) stock pays dividends to shareholders. As of July 11, 2025, the dividend rate is €0.1 and the yield is 0.84%. RHÖN-KLINIKUM Aktiengesellschaft has a payout ratio of 0% on a trailing twelve-month basis.
When is the next RHÖN-KLINIKUM Aktiengesellschaft dividend payment date?
The next RHÖN-KLINIKUM Aktiengesellschaft (RHK) dividend payment date is unconfirmed.
What is the beta indicator for RHÖN-KLINIKUM Aktiengesellschaft?
RHÖN-KLINIKUM Aktiengesellschaft (RHK) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.